Family · Pharmaceutical analytical standards
Ciprofloxacin
A broad-spectrum fluoroquinolone antibiotic that blocks the bacterial enzymes DNA gyrase and topoisomerase IV, patented in 1980 and on the market since 1987: it is on the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Its family began with a by-product: the first quinolone, nalidixic acid, was isolated during the synthesis of the antimalarial chloroquine and introduced in the 1960s.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
